1. Home
  2. BIO vs LAD Comparison

BIO vs LAD Comparison

Compare BIO & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • LAD
  • Stock Information
  • Founded
  • BIO 1952
  • LAD 1946
  • Country
  • BIO United States
  • LAD United States
  • Employees
  • BIO N/A
  • LAD N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • LAD Retail-Auto Dealers and Gas Stations
  • Sector
  • BIO Industrials
  • LAD Consumer Discretionary
  • Exchange
  • BIO Nasdaq
  • LAD Nasdaq
  • Market Cap
  • BIO 6.6B
  • LAD 7.4B
  • IPO Year
  • BIO N/A
  • LAD 1996
  • Fundamental
  • Price
  • BIO $264.53
  • LAD $293.74
  • Analyst Decision
  • BIO Strong Buy
  • LAD Strong Buy
  • Analyst Count
  • BIO 4
  • LAD 13
  • Target Price
  • BIO $333.50
  • LAD $383.38
  • AVG Volume (30 Days)
  • BIO 342.3K
  • LAD 394.8K
  • Earning Date
  • BIO 07-31-2025
  • LAD 07-29-2025
  • Dividend Yield
  • BIO N/A
  • LAD 0.75%
  • EPS Growth
  • BIO N/A
  • LAD 8.81
  • EPS
  • BIO 11.49
  • LAD 33.70
  • Revenue
  • BIO $2,554,200,000.00
  • LAD $37,155,800,000.00
  • Revenue This Year
  • BIO N/A
  • LAD $5.48
  • Revenue Next Year
  • BIO $3.42
  • LAD $5.82
  • P/E Ratio
  • BIO $22.99
  • LAD $8.66
  • Revenue Growth
  • BIO N/A
  • LAD 10.11
  • 52 Week Low
  • BIO $211.43
  • LAD $255.32
  • 52 Week High
  • BIO $387.99
  • LAD $405.68
  • Technical
  • Relative Strength Index (RSI)
  • BIO 55.27
  • LAD 39.29
  • Support Level
  • BIO $261.65
  • LAD $291.17
  • Resistance Level
  • BIO $270.71
  • LAD $300.82
  • Average True Range (ATR)
  • BIO 8.66
  • LAD 8.07
  • MACD
  • BIO -0.13
  • LAD 0.10
  • Stochastic Oscillator
  • BIO 46.22
  • LAD 31.62

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About LAD Lithia Motors Inc.

Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.

Share on Social Networks: